Comparison of Preloading vs. Co-loading With Crystalloids to Prevent Spinal Anaesthesia-Induced Hypotension

November 9, 2026 updated by: Pavel Azeez

The purpose of this study is to compare the effectiveness of crystalloid pre-load with co-load intravenous fluid in the prevention of spinal anaesthesia-induced hypotension during elective caesarean sections and to assess the incidence of nausea, vomiting, bradycardia, and the requirement for vasopressors.

Study Overview

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Erbil, Iraq
        • Erbil maternaty hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • aged 18-40 years.
  • elective caesarean.
  • singleton pregnancy.
  • American Society of Anaesthesiologists (ASA) classification of class I or II.

Exclusion Criteria:

  • Pregnancy-induced hypertension or preeclampsia.
  • multiple pregnancies.
  • BMI greater than 35 kg/m².
  • contraindications to spinal anaesthesia.
  • emergency caesarean sections.
  • past medical history of cardiovascular disease and diabetes mellitus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Maternal hpotension

The pre-load group received Ringer lactate 15 mL/kg over 15-20 minutes before induction of spinal anaesthesia,

the co-load group received Ringer lactate 15 mL/kg immediately after intrathecal injection.

Active Comparator: No maternal hypotension

The pre-load group received Ringer lactate 15 mL/kg over 15-20 minutes before induction of spinal anaesthesia,

the co-load group received Ringer lactate 15 mL/kg immediately after intrathecal injection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Spinal Anaesthesia-Induced Hypotension
Time Frame: Through surgery completion, an average of 20 mins

Proportion of participants who develop hypotension following spinal anaesthesia in the preloading and co-loading groups.

Through surgery completion, an average of 20 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2025

Primary Completion (Actual)

October 31, 2025

Study Completion (Actual)

November 30, 2025

Study Registration Dates

First Submitted

October 30, 2026

First Submitted That Met QC Criteria

November 9, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 9, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Erbil maternity hospital

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe